JOE WEST JOE.WEST@NOTTINGHAM.AC.UK
Professor of Epidemiology
Incidence and survival of haemophagocytic lymphohistiocytosis: A population‐based cohort study from England
West, Joe; Card, Tim R.; Bishton, Mark J.; Lanyon, Peter; Ban, Lu; Bythell, Mary; Elliss-Brookes, Lucy; Manson, Jessica J.; Nanduri, Vasanta; Rankin, Judith; Tattersall, Rachel S.; Crooks, Colin J.
Authors
Dr TIM CARD tim.card@nottingham.ac.uk
Clinical Associate Professor
Mark J. Bishton
Peter Lanyon
Lu Ban
Mary Bythell
Lucy Elliss-Brookes
Jessica J. Manson
Vasanta Nanduri
Judith Rankin
Rachel S. Tattersall
Dr COLIN CROOKS Colin.Crooks@nottingham.ac.uk
Clinical Associate Professor
Abstract
Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare hyper-inflammatory condition with poor outcomes. Objectives: Few population-based estimates of the incidence and survival in adults exist. We aimed to provide these data for England. Methods: We used population-based linked data from primary care, secondary care, cancer registries and mortality databases in England to identify people diagnosed with HLH between 1 January 2000 and 31 December 2016. We calculated annual incidence rates by age and sex, modelled change in incidence over time with Poisson regression, calculated overall 1-year survival using Kaplan–Meier methods and estimated adjusted hazard ratios (HRs) of death using a Cox proportional hazards model. Results: We identified 214 patients with HLH. The reported age and sex-adjusted incidence increased twofold over the period, from around one to around two per million. Incidence was highest in those below 1 year (14.6 per million) and ≥75 years (2.2 per million), and lowest in those aged 15–44 years (0.8 per million). One-year survival varied by age and sex from 77% (95% confidence interval [CI] 63%–86%) in those <15 years to 30% (95% CI 14%–49%) in those ≥75. In patients with haematological cancer, the adjusted HR for death was 2.60 (95% CI 1.45–4.66) compared to patients with no malignant or rheumatological disease. Conclusion: The incidence of HLH diagnosis in England has increased between 2000 and 2016 and occurs in all ages with varying underlying diseases. One-year survival varies substantially, being particularly poor in those aged over 75 years and those with haematological malignancy.
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 7, 2021 |
Online Publication Date | Dec 22, 2021 |
Publication Date | Apr 1, 2022 |
Deposit Date | Nov 23, 2021 |
Publicly Available Date | Dec 23, 2022 |
Journal | Journal of Internal Medicine |
Print ISSN | 0954-6820 |
Electronic ISSN | 1365-2796 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 291 |
Issue | 4 |
Pages | 493-504 |
DOI | https://doi.org/10.1111/joim.13432 |
Keywords | HLH; epidemiology; incidence; survival |
Public URL | https://nottingham-repository.worktribe.com/output/6785089 |
Publisher URL | https://onlinelibrary.wiley.com/doi/10.1111/joim.13432 |
Additional Information | Published: 2021-12-22 |
Files
West J Intern Med 2021 AAM
(563 Kb)
PDF
You might also like
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search